跳至主要内容
临床试验/CTRI/2023/03/051212
CTRI/2023/03/051212尚未招募2 期

Randomized control trial to evaluate the efficacy of Triphaladi Guggulu Vati and its add on effect with Tablet Thyroxin in Hypothyroidism.

DR.RAHUL ISHWARLAL DESAI0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Age - 18 to 60yrs
  • 2) Gender -both male and female patients will be
  • selected irrespective of religion and economic
  • 3) Known case of Hypothyroidism initiated on
  • treatment not more than 5 years and newly
  • Diagnosed case of Hypothyroidism By clinical
  • parameters, Zulewskiâ??s Clinical Score and
  • Thyroid Function Test, FreeT4, and TSH ( >5.5
  • micro IU/ml)

排除标准

  • 1) Patients Suffering From Co-Morbid or Life
  • Threatening Elements.
  • 2)Known Case of Congenital Hypothyroidism or
  • Anatomical Deformity Related To Thyroid Gland
  • 3)Known Case of Thyroid Neoplasia.
  • 4)Known Case of Progressive Case of Myxoedema
  • 5)Known Case of Infiltrative Disorders like
  • Sarcoidosis Etc.
  • 6)Individual Suffering From Immune Compromised
  • Diseases or Patients on Immunocompressive Drugs.
  • 7)Pregnancy
  • 8)Known Case of Hypothyroidism Caused Due to the
  • Administration of Chemotherapy Radiotherapy Post I -131 Therapy And Post Thyroidectomy

研究者

发起方
DR.RAHUL ISHWARLAL DESAI

相似试验